Global efforts to develop and adopt innovative regulatory practices to reduce the environmental impact of medicines have picked up pace after the World Health Organization (WHO) issued a call to action to regulators and pharmaceutical industry stakeholders to adopt innovative processes that prioritize the sector’s sustainability and reduce its environmental impact.
WHO Issues Environmental Sustainability Call To Regulators And Pharmaceutical Industry
The World Health Organization (WHO) has launched an initiative to highlight the pressing global need to reduce the impact of the pharmaceutical industry on the environment while maintaining high standards of safety and efficacy for products.
